Mouse models of autism spectrum disorders: The challenge for behavioral genetics

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 142 C, Issue 1, 2006, Pages 40-51

  Moy, Sheryl S ^a,b,g   Nadler, Jessica J ^c   Magnuson, Terry R ^d,e   Crawley, Jacqueline N ^b,f  

^a Neurodevelopmental Disorders Research Center   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNC   (United States)

^d UNC Department of Genetics

^e Carolina Center for Genome Sciences   (United States)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Fragile X; Mice; Repetitive behavior; Rett syndrome; Social interaction

Indexed keywords

ANIMAL MODEL; AUTISM; BEHAVIOR GENETICS; COMMUNICATION DISORDER; DEVELOPMENTAL DISORDER; FRAGILE X SYNDROME; HERITABILITY; MOUSE; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; SEROTONINERGIC SYSTEM; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

ANIMALS; BEHAVIOR, ANIMAL; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DISEASE MODELS, ANIMAL; GENETICS, BEHAVIORAL; HUMANS; MICE;

ANIMALIA;

EID: 32444451616     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30081     Document Type: Review

References (134)

1. Alberi L, Sgado P, Simon HH. 2004. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development 131:3229-3236.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders (DSM-IV). Washington, DC.
3. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185-188.
4. Anderson GM, Horne WC, Chatterjee D, Cohen DJ. 1990. The hyperserotoninemia of autism. Ann NY Acad Sci 600:331-340.
5. Aylward EH, Minshew NJ, Goldstein G, Honeycutt NA, Augustine AM, Yates KO, Barta PE, Pearlson GD. 1999. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 53:2145-2150.
6. Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter M, Lantos P. 1998. A clinicopathological study of autism. Brain 121:889-905.
7. Bakker CE, Verheij C, Willemsen R, van der Helm R, Oerlemans F, Vermey M, Bygrave A, Hoogeveen AT, Oostra BA, Reyniers E, De Boulle K, D'Hooge R, Cras P, van Velzen D, Nagels G, Martin J-J, De Deyn PP, Darby JK, Willems PJ. 1994. Fmr1 knockout mice: A model to study fragile X mental retardation. Cell 78:23-33.
8. Balogh SA, McDowell CS, Stavnezer AJ, Denenberg VH. 1999. A behavioral and neuroanatomical assessment of an inbred substrain of 129 mice with behavioral comparisons to C57BL/6J mice. Brain Res 836:38-48.
9. Baranek GT. 2002. Efficacy of sensory and motor interventions for children with autism. J Autism Dev Disord 32:397-422.
10. Barton M, Volkmar F. 1998. How commonly are known medical conditions associated with autism? J Aut Dev Dis 28:273-278.
11. Bell K, Shokrian D, Potenzieri C, Whitaker-Azmitia PM. 2003. Harm avoidance, anxiety, and response to novelty in the adolescent S-100B transgenic mouse: Role of serotonin and relevance to Down syndrome. Neuropsychopharmacol 28:1810-1816.
12. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Wekphal H, Lesch KP. 1998. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 53:649-655.
13. Bodfish JW, Symons FJ, Parker DE, Lewis M. 2000. Varieties of repetitive behavior in autism: Comparisons to mental retardation. J Aut Dev Disorders 30:237-243.
14. Bonora E, Beyer KS, Lamb JA, Parr JR, Klauck SM, Benner A, Paolucci M, Abbott A, Ragoussis I, Poustka A, Bailey AJ, Monaco AP. International Molecular Genetic Study of Autism (IMGSAC). 2003. Analysis of reelin as a candidate gene for autism. Mol Psychiatry 8:885-892.
15. Bouwknecht JA, Paylor R. 2002. Behavioral and physiological mouse assays for anxiety: A survey in nine mouse strains. Behav Brain Res 136:489-501.
16. Brodkin ES, Hagemann A, Nemetski SM, Silver LM. 2004. Social approach-avoidance behavior of inbred mouse strains towards DBA/2 mice. Brain Res 1002:151-157.
17. Buxbaum JD, Silverman JM, Smith CJ, Greenberg DA, Kilifarski M, Reichert J, Cook EH Jr, Fang Y, Song C-Y, Vitale R. 2002. Association between a GABRB3 polymorphism and autism. Mol Psychiatry 7:311-316.
18. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Muller U, Aguet M, Babinet C, Shih JC, De Maeyer E. 1995. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268:1763-1766.
19. Chen L, Toth M. 2001. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103:1043-1050.
20. Chen RZ, Akbarian S, Tudor M, Jaenisch R. 2001. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327-331.
21. Cohen IL, Liu X, Schutz C, White BN, Jenkins EC, Brown WT, Holden JJA. 2003. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet 64:190-197.
22. Collaborative Linkage Study of Autism. 1999. An autosomal genomic screen for autism. Am J Med Genet (Neuropsychiatr Genet) 88:609-615.
23. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, Greenough WT. 1997. Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits. Proc Natl Acad Sci 94:5401-5404.
24. Conroy J, Meally E, Kearney G, Fitzgerald M, Gill M, Gallagher L. 2004. Serotonin transporter gene and autism: A haplotype analysis in an Irish autistic population. Mol Psychiatry 9:587-593.
25. Cook EH, Leventhal BL. 1996. The serotonin system in autism. Curr Opin Pediatr 8:348-354.
26. Costa RM, Yang T, Huynh DP, Pulst SM, Viskochil DH, Silva AJ, Brannan CI. 2001. Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet 27:399-405.
27. Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ. 2002. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415:526-530.
28. Courchesne E, Karns CM, Davis HR, Ziccardi R, Carper RA, Tigue ZD, Chisum HJ, Moses P, Pierce K, Lord C, Lincoln AJ, Pizzo S, Schreibman L, Haas RH, Akshoomoff NA, Courchesne RY. 2001. Unusual brain growth patterns in early life in patients with autistic disorder. An MRI study. Neurology 57:245-254.
29. Darnell JC, Fraser CE, Mostovetsky O, Stefani G, Jones TA, Eddy SR, Darnell RB. 2005. Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev 19:903-918.
30. A receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci 18:8505-8514.
31. Dobkin C, Rabe A, Dumas R, El Idrissi A, Haubenstock H, Brown WT. 2000. Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neurosci 100:423-429.
32. Driscoll LL, Carroll JC, Moon J, Crnic LS, Levitsky DA, Strupp BJ. 2004. Impaired sustained attention and error-induced stereotypy in the aged Ts65Dn mouse: A mouse model of Down syndrome and Alzheimer's disease. Behav Neurosci 118:1196-1205.
33. Duncan GE, Moy SS, Perez A, Eddy DM, Zinow W, Lieberman JA, Snouwaert JN, Koller BH. 2004. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 153:507-518.
34. Falconer DS. 1951. Two new mutants. J Genet 50:192-201.
35. Fatemi SH. 2001. Reelin mutations in mouse and man: From reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol Psychiatry 6:129-133.
36. Fatemi SH. 2005. Reelin glycoprotein: Structure, biology and roles in health and disease. Mol Psychiatry 10:251-257.
37. Fatemi SH, Realmuto GM, Khan L, Thuras P. 1998. Fluoxetine in treatment of adolescent patients with autism: A longitudinal open trial. J Aut Dev Disorders 28:303-307.
38. Fisch GS, Hao HK, Bakker C, Oostra BA. 1999. Learning and memory in the FMR1 knock-out mouse. Am J Med Genet 84:277-282.
39. Fitzky BU, Witsch-Baumgartner M, Erdel M, Lee J-N, Paik Y-K, Glossmann H, Utermann G, Moebius FF. 1998. Mutations in the 7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci USA 95:8181-8186.
40. Fitzky BU, Moebius FF, Asaoka H, Waage-Baudet H, Xu L, Xu G, Maeda N, Kluckman K, Hiller S, Yu H, Batta AK, Shefer S, Chen T, Salen G, Sulik K, Simoni RD, Ness GC, Glossmann H, Patel SB, Tint GS. 2001. 7-dehydrocholesterol- dependentproteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J Clin Invest 108:905-915.
41. Folstein SE, Rosen-Sheidley B. 2001. Genetics of autism: Complex aetiology for a heterogeneous disorder. Nat Rev Genet 2:943-955.
42. Fombonne E. 2002. Epidemiological trends in rates of autism. Mol Psychiatry 7:S4-S6.
43. Frankland PW, Wang Y, Rosner B, Shimizu T, Balleine BW, Dykens EM, Ornitz EM, Silva AJ. 2004. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry 9:417-425.
44. Gerlai R, Millen KJ, Herrup K, Fabien K, Joyner AL, Roder J. 1996. Impaired motor learning performance in cerebellar En-2 mutant mice. Behav Neurosci 110:126-133.
45. Gharani N, Benayed R, Mancuso V, Brzustowicz LM, Millonig JH. 2004. Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol Psychiatry 9(5):474-484.
46. Gillberg C, Billstedt E. 2000. Autism and Asperger syndrome: Coexistence with other clinical disorders. Acta Psychiatr Scand 102:321-330.
47. Gingrich JA, Hen R. 2001. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology 155:1-10.
48. Griebel G, Belzung C, Perrault G, Sanger DJ. 2000. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology 148:164-170.
49. Guy J, Hendrich B, Holmes M, Martin JE, Bird A. 2001. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322-326.
50. Hagerman RJ, Jackson AWIII, Levitas A, Rimland B, Braden M. 1986. An analysis of autism in fifty males with the fragile X syndrome. Am J Med Genet 23:359-374.
51. Happé F, Ehlers S, Fletcher P, Frith U, Johansson M, Gillberg C, Dolan R, Frackowiak R, Frith C. 1996. "Theory of mind" in the brain. Evidence from a PET scan study of Asperger syndrome. Neuro Report 8(1):197-201.
52. Hodge RD, D'Ercole AJ, O'Kusky JR. 2005. Increased expression of insulin-like growth factor-I (IGF-I) during embryonic development produces neocortical overgrowth with differentially greater effects on specific cytoarchitectonic areas and cortical layers. Dev Brain Res 154:227-237.
53. Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, Iyengar R. 2005. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 30:582-589.
54. Holmes A, Yang RJ, Murphy DL, Crawley JN. 2002. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27(6):914-923.
55. Holmes A, Li Q, Murphy DL, Gold E, Crawley JN. 2003. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: The influence of genetic background. Genes Brain Behav 2(6):365-380.
56. Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE, Johnson RM, Chen K, Sun Y, Carlson E, Alleva E, Epstein CJ, Mobley WC. 1996. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci 93:13333-13338.
57. Homanics GE, DeLorey TM, Firestone LL, Quinlan JJ, Handforth A, Harrison NL, Krasowski MD, Rick CEM, Korpi ER, Makela R, Brilliant MH, Hagiwara N, Ferguson C, Synder K, Olsen RW 1997. Mice devoid of α-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA 94:4143-4148.
58. IMGSAC. 2001. A genomewide screen for autism: Strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 69:570-581.
59. Ingram JL, Stodgell CJ, Hyman SL, Figlewicz DA, Weitkamp LR, Rodier PM. 2000. Discovery of allelic variants of HOXA1 and HOXB1: Genetic susceptibility to autism spectrum disorders. Teratology 62:393-405.
60. Insel TR. 2001. Mouse models for autism: Report from a meeting. Mamm Genome 12:755-757.
61. Insel TR, O'Brien DJ, Leckman JF. 1999. Oxytocin, vasopressin, and autism: Is there a connection? Biol Psychiatry 45:145-157.
62. Jiang Y, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G, Sweatt JD, Beaudet AL. 1998. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21:799-811.
63. Joyner AL, Herrup K, Auerbach BA, Davis CA, Rossant J. 1991. Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox. Science 251:1239-1243.
64. Keller F, Persico AM. 2003. The neurobiological context of autism. Mol Neurobiol 28:1-22.
65. Kim JJ, Shih JC, Chen K, Chen L, Bao S, Maren S, Anagnostaras SG, Fanselow MS, Maeyer ED, Seif I, Thompson RF. 1997. Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. Proc Natl Acad Sci 94:5929-5933.
66. Kim S-J, Cox N, Courchesne R, Lord C, Corsello C, Akshoomoff N, Guter S, Leventhal BL, Courchesne E, Cook EH Jr. 2002. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry 7:278-288.
67. Kooy RF, D'Hooge R, Reyniers E, Bakker CE, Nagels G, De Boulle K, Storm K, Clincke G, De Deyn PP, Oostra BA, Willems PJ. 1996. Transgenic mouse model for the fragile X syndrome. American J Med Gen 64:241-245.
68. Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Baker E, Warren ST, Schlessinger D, Sutherland GR, Richards RI. 1991. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252:1711-1714.
69. rl-orl mutant mice and correlations with cytochrome oxidase activity. Neurosci Res 49:297-305.
70. Larson J, Hoffman JS, Guidotti A, Costa E. 2003. Olfactory discrimination learning deficit in heterozygous reeler mice. Brain Res 971:40-46.
71. Lijam N, Paylor R, McDonald MP, Crawley JN, Deng C-X, Herrup K, Stevens KE, Maccaferri G, McBain CJ, Sussman DJ, Wynshaw-Boris A. 1997. Social interaction and sensorimotor gating abnormalities in mice lacking Dv/1. Cell 90:895-905.
72. 3 subunit levels, EEG, and behavior. Dev Brain Res 157:150-161.
73. Lim MM, Bielsky IF, Young LJ. 2005. Neuropeptides and the social brain: Potential rodent models of autism. Int J Devl Neurosci 23:235-243.
74. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, Underwood MD, Arango V, Kung HF, Hofer MA, Hen R, Gingrich JA. 2003. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Bio Psychiatry 54:960-971.
75. Liu WS, Pesold C, Rodriguez MA, Carboni G, Auta J, Lacor P, Larson J, Condie BG, Guidotti A, Costa E. 2001. Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc Natl Acad Sci 98:3477-3482.
76. Liu W, Pappas GD, Carter CS. 2005. Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/-) reeler mice. Neurol Res 27(4):339-345.
77. Long JM, LaPorte P, Paylor R, Wynshaw-Boris A. 2004. Expanded characterization of the social interaction abnormalities in mice lacking Dvl1. Genes Brain Behav 3:51-62.
78. Lufkin T, Dierich A, LeMeur M, Mark M, Chambon P. 1991. Disruption of the Hox-1.6 homeobox gene results in defects in a region corresponding to its rostral domain of expression. Cell 66:1105-1119.
79. Martinez-Cue C, Baamonde C, Lumbreras MA, Vallina IF, Dierssen M, Florez J. 1999. A murine model for Down syndrome shows reduced responsiveness to pain. Neuroreport 10:1119-1122.
80. Mineur YS, Sluyter F, de Wit S, Oostra BA, Crusio WE. 2002. Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus 12:39-46.
81. Miura K, Kishino T, Li E, Webber H, Dikkes P, Holmes GL, Wagstaff J. 2002. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobio Dis 9:149-159.
82. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. 1999. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436.
83. Moles A, Kieffer BL, D'Amato F. 2004. Deficit in attachment behavior in mice lacking the μ-opioid receptor gene. Science 304:1983-1986.
84. Monkley SJ, Delaney SJ, Pennisi DJ, Christiansen JH, Wainwright BJ. 1996. Targeted disruption of the Wnt2 gene results in placentation defects. Development 122:3343-3353.
85. Moretti P, Bouwknecht JA, Teague R, Paylor R, Zoghbi HY. 2005. Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum Mol Gen 14:205-220.
86. Moy SS, Nadler JJ, Perez A, Barbara RP, Johns JM, Magnuson TR, Piven J, Crawley JN. 2004. Sociability and preference for social novelty in five inbred strains: An approach to assess autistic-like behavior in mice. Genes Brain Behav 3:287-302.
87. Murcia CL, Gulden F, Herrup K. 2004. A question of balance: A proposal for new mouse models of autism. Int J Devl Neurosci 23:265-275.
88. Muris P, Steerneman P, Merckelbach H, Holdrinet I, Meesters C. 1998. Comorbid anxiety symptoms in children with pervasive developmental disorders. J Anxiety Dis 12:387-393.
89. Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, Young NB, Barbaro RP, Piven J, Magnuson T, Crawley JN. 2004. Automated apparatus for rapid quantitation of autism-like social deficits in mice. Genes Brain Behav 3:303-314.
90. Nan X, Ng H-H, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389.
91. Nielson DM, Derber WJ, McClellan DA, Crnic LS. 2002. Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome. Brain Res 927:8-17.
92. North K. 2000. Neurofibromatosis type 1. Am J Med Genet 97:119-127.
93. Nurmi EL, Bradford Y, Chen Y, Hall J, Arnone B, Gardiner MB, Hutcheson HB, Gilbert JR, Pericak-Vance MA, Copeland-Yates SA, Michaelis RC, Wassink TH, Santangelo SL, Sheffield VC, Piven J, Holstein SE, Haines JL, Sutcliffe JS. 2001. Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families. Genomics 77:105-113.
94. Oostra BA, Chiurazzi P. 2001. The fragile X gene and its function. Clin Genet 60:399-408.
95. Palmen SJMC, van Engeland H, Hof PR, Schmitz C. 2004. Neuropathological findings in autism. Brain 127:2572-2583.
96. Paradee W, Melikian HE, Rasmussen DL, Kenneson A, Conn PJ, Warren ST. 1999. Fragile X mouse: Strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 94:185-192.
97. Peier AM, McIlwain KL, Kenneson A, Warren ST, Paylor R, Nelson DL. 2000. (Over)-correction of FMR1 deficiency with YAC transgenics: Behavioral and physical features. Human Mol Genet 9(8):1145-1159.
98. Persico AM, D'Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C, Wassink TH, for the CLSA, Schneider C, Melmed R, Trillo S, Montecchi F, Palermo M, Pascucci T, Puglisi-Allegra S, Reichelt K-L, Conciatori M, Marino R, Quattrocchi CC, Baldi A, Zelante L, Gasparini P, Keller F. 2001. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry 6:150-159.
99. Piven J, Arndt S, Bailey J, Andreasen N. 1996. Regional brain enlargement in autism: A magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry 35:530-536.
100. Piven J, Bailey J, Ranson BJ, Arndt S. 1997. An MRI study of the corpus callosum in autism. Am J Psychiatry 154:1051-1056.
101. Popova NK, Vishnivetskaya GB, Ivanova EA, Skrinskaya JA, Seif I. 2000. Altered behavior and alcohol tolerance in transgenic mice lacking MAO A: A comparison with effects of MAO A inhibitor clorgyline. Pharmacol Biochem Behav 67:719-727.
102. Presti MF, Watson CJ, Kennedy RT, Yang M, Lewis MH. 2003. Behavior-related alterations of striatal neurochemistry in a mouse model of stereotyped movement disorder. Pharmacol Biochem Behav 77(3):501-507.
103. Ren-Patterson RF, Cochran LW, Holmes A, Sherrill S, Huang S-J, Tolliver T, Lesch K-P, Lu B, Murphy DL. 2005. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res 79:756-771.
104. Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J, Kalaydjieva L, McCague P, Dimiceli S, Pitts T, Nguyen L, Yang J, Harper C, Thorpe D, Vermeer S, Young H, Hebert J, Lin A, Ferguson J, Chiotti C, Wiese-Slater S, Rogers T, Salmon B, Nicholas P, Petersen PB, Pingree C, McMahon W, Wong DL, Cavalli-Sforza LL, Kraemer HC, Myers RM. 1999. A genomic screen of autism: Evidence for a multilocus etiology. Am J Hum Genet 65:493-507.
105. Rodier PM. 1996. Animal model of autism based on developmental data. Mental Retard Dev Dis Res Rev 2:249-256.
106. Rodriguiz RA, Chu R, Caron MG, Wetsel WC. 2004. Aberrant responses in social interaction of dopamine transporter knockout mice. Behav Brain Res 148:185-198.
107. Rosso SB, Sussman D, Wynshaw-Boris A, Salinas PC. 2005. Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nat Neurosci 8:34-42.
108. Sago H, Carlson EJ, Smith DJ, Kilbridge J, Rubin EM, Mobley WC, Epstein CJ, Huang T-T. 1998. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci 95:6256-6261.
109. Saitoh O, Karns CM, Courchesne E. 2001. Development of the hippocampal formation from 2 to 42 years: MRI evidence of smaller area dentata in autism. Brain 124:1317-1324.
110. Salinger WL, Ladrow P, Wheeler C. 2003. Behavioral phenotype of the reeler mutant mouse: Effects of Reln gene dosage and social isolation. Behav Neurosci 117:1257-1275.
111. Samaco RC, Hogatt A, LaSalle JM. 2005. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Human Mol Genet 14:483-492.
112. Schultz RT, Gauthier I, Klin A, Fulbright RK, Anderson AW, Volkmar F, Skudlarski P, Lacadie C, Cohen DJ, Gore JC. 2000. Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry 57:331-340.
113. Shahbazian MD, Young JI, Yuva-Paylor LA, Spencer CM, Antalffy BA, Noebels JL, Armstrong DL, Paylor R, Zoghbi HY. 2002. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35:243-254.
114. Shibayama A, Cook EH Jr, Feng J, Glanzmann C, Yan J, Craddock N, Jones IR, Goldman D, Heston LL, Sommer SS. 2004. MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism. Am J Med Genet PartB 128B:50-53.
115. Silva AJ, Frankland PW, Marowitz Z, Friedman E, Lazlo G, Cioffi D, Jacks T, Bourtchuladze R. 1997. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet 15:281-284.
116. Simon HH, Scholz C, O'Leary DD. 2005. Engrailed genes control developmental fate of serotonergic and noradrenergic neurons in mid- and hindbrain in a gene dose-dependent manner. Mol Cell Neurosci 28:96-105.
117. Skaar DA, Shao Y, Haines JL, Stenger JE, Jaworski J, Martin ER, Delong GR, Moore JH, McCauley JL, Sutcliffe JS, Ashley-Koch AE, Cuccaro ML, Folstein SE, Gilbert JR, Pericak-Vance MA. 2004. Analysis of the RELN gene as a genetic risk factor for autism. Mol Psychiatry 10:563-571.
118. Spencer CM, Alekseyenko O, Serysheva E, Yuva-Paylor LA, Paylor R. 2005. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav 4(7):420-430.
119. The Jackson Laboratory. 2002. Genetic background effects: Can your mice see? JAX/Notes 485:2.
120. Tuetling P, Costa E, Dwivedi Y, Guidotti A, Impagnatiello F, Manev R, Pesold C. 1999. The phenotypic characteristics of heterozygous reeler mouse. Neuro Report 10:1329-1334.
121. Turner CA, Presti MF, Newman HA, Bugenhagen P, Crnic L, Lewis MH. 2001. Spontaneous stereotypy in an animal model of Down syndrome: Ts65Dn mice. Behav Genet 31:393-400.
122. Vincent JP, Lawrence PA. 1994. Drosophila wingless sustains engrailed expression only in adjoining cells: Evidence from mosaic embryos. Cell 77:909-915.
123. Wagstaff J, Knoll JHM, Fleming J, Kirkness EF, Martin-Gallardo A, Greenberg F, Graham JM Jr, Menninget J, Ward D, Venter JC, Lalande M. 1991. Localization of the gene encoding the GABA(A) receptor beta-3 subunit to the Angelman/Prader-Willi region of human chromosome 15. Am J Hum Genet 49:330-337.
124. 1B knockout mice: Implications of absent corpus callosum. Behav Brain Res 125:23-32.
125. Wan M, Lee SSJ, Zhang X, Houwink-Manville I, Song H-R, Amir RE, Budden S, Naidu S, Pereira JLP, Lo IFM, Zoghbi HY, Schanen NC, Francke U. 1999. Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 65:1520-1529.
126. Wassif CA, Zhu P, Kratz L, Krakowiak PA, Battaile KP, Weight FF, Grinberg A, Steiner RD, Nwokoro NA, Kelley RI, Stewart RR, Porter FD. 2001. Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith-Lemli-Opitz syndrome. Hum Mol Genet 10:555-564.
127. Wassink TH, Piven J, Vieland VJ, Huang J, Swiderski RE, Pietila J, Braun T, Beck G, Folstein SE, Haines JL, Sheffield VC. 2001. Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genet 105:406-413.
128. Williams CA. 2005. Neurological aspects of the Angelman syndrome. Brain Dev 27:88-94.
129. Wilson C, Idziaszczyk S, Parry L, Guy C, Griffiths DF, Lazda E, Bayne RA, Smith AJ, Sampson JR, Cheadle JP. 2005. A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma. Hum Mol Genet 14:1839-1850.
130. Wu C-L, Melton DW 1993. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice. Nat Genet 3:235-239.
131. Yan QJ, Asafo-Adjei PK, Arnold HM, Brown RE, Bauchwitz RP. 2004. A phenotypic and molecular characterization of the fmr1-tm1Cgr Fragile X mouse. Genes Brain Behav 3:337-359.
132. Yu H, Wessels A, Tint GS, Patel SB. 2005. Partial rescue of neonatal lethality of Dhcr7 null mice by a nestin promotor-driven DHCR7 transgene expression. Dev Brain Res 156:46-60.
133. Zappella M, Meloni I, Longo I, Hayek G, Renieri A. 2001. Preserved speech variants of the Rett syndrome: Molecular and clinical analysis. Am J Med Genet 104:14-22.
134. Zhuang X, Gross C, Santarelli L, Compan V, Trillat A-C, Hen R. 1999. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 21(2S):52S-60S.